🇺🇸 FDA
Patent

US 7531162

Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation

granted A61KA61K47/551A61P

Quick answer

US patent 7531162 (Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation) held by Regents of the University of Minnesota expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/551, A61P, A61P35/00